News
The North America Osteoporosis Treatment Market is experiencing robust growth, anticipated to achieve a CAGR of 7.5% from 2022 to 2028, as per a comprehensive study by Report Ocean, a leading ...
PROTEOR, a global leader in prosthetics and orthotics (O&P), announced today the expansion of its Digital solutions and a first-in-the-industry innovation: The production of non-vase mode definitive ...
Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the U.S. against Amgen for ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling ...
Shares of Amgen Inc. AMGN rose 1.62% to $285.98 Friday, on what proved to be an all-around great trading session for the ...
Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results